• Je něco špatně v tomto záznamu ?

Chitosan derivatives with antimicrobial, antitumour and antioxidant activities--a review

Jarmila Vinšová, Eva Vavríková

. 2011 ; 17 (32) : 3596-3607.

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc12022205

Grantová podpora
NS10367 MZ0 CEP - Centrální evidence projektů

Chitosan is a linear polysaccharide with a good biodegradability, biocompatibility, and no toxicity, which provide it with huge potential for future development. The chitosan molecule appears to be a suitable polymeric complex for many biomedical applications. This review gathers current findings on the antibacterial, antifungal, antitumour and antioxidant activities of chitosan derivatives and concurs with our previous review presenting data collected up to 2008. Antibacterial activity is based on molecular weight, the degree of deacetylation, the type of substitutents, which can be cationic or easily form cations, and the type of bacterium. In general, high molecular weight chitosan cannot pass through cell membranes and forms a film that protects cells against nutrient transport through the microbial cell membrane. Low molecular weight chitosan derivatives are water soluble and can better incorporate the active molecule into the cell. Gram-negative bacteria, often represented by Escherichia coli, have an anionic bacterial surface on which cationic chitosan derivatives interact electrostatically. Thus, many chitosan conjugates have cationic components such as ammonium, pyridinium or piperazinium substituents introduced into their molecules to increase their positive charge. Gram-positive bacteria like Staphylococcus aureus are inhibited by the binding of lower molecular weight chitosan derivatives to DNA or RNA. Chitosan nanoparticles exhibit an increase in loading capacity and efficacy. Antitumour active compounds such as doxorubicin, paclitaxel, docetaxel and norcantharidin are used as drug carriers. It is evident that chitosan, with its low molecular weight, is a useful carrier for molecular drugs requiring targeted delivery. The antioxidant scavenging activity of chitosan has been established by the strong hydrogen-donating ability of chitosan. The low molecular weight and greater degree of quarternization have a positive influence on the antioxidant activity of chitosan. Phenolic and polyphenolic compounds with antioxidant effects are condensed with chitosan to form mutual prodrugs.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12022205
003      
CZ-PrNML
005      
20160308083213.0
007      
ta
008      
120806s2011 ne f 000 0#eng||
009      
AR
024    7_
$a 10.2174/138161211798194468 $2 doi
035    __
$a (PubMed)22074429
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Vinšová, Jarmila, $u Charles University, Faculty of Pharmacy, Department of Inorganic and Organic Chemistry, Hradec Králové, Czech Republic. vinsova@faf.cuni.cz $d 1951- $7 nlk19990073991
245    10
$a Chitosan derivatives with antimicrobial, antitumour and antioxidant activities--a review / $c Jarmila Vinšová, Eva Vavríková
520    9_
$a Chitosan is a linear polysaccharide with a good biodegradability, biocompatibility, and no toxicity, which provide it with huge potential for future development. The chitosan molecule appears to be a suitable polymeric complex for many biomedical applications. This review gathers current findings on the antibacterial, antifungal, antitumour and antioxidant activities of chitosan derivatives and concurs with our previous review presenting data collected up to 2008. Antibacterial activity is based on molecular weight, the degree of deacetylation, the type of substitutents, which can be cationic or easily form cations, and the type of bacterium. In general, high molecular weight chitosan cannot pass through cell membranes and forms a film that protects cells against nutrient transport through the microbial cell membrane. Low molecular weight chitosan derivatives are water soluble and can better incorporate the active molecule into the cell. Gram-negative bacteria, often represented by Escherichia coli, have an anionic bacterial surface on which cationic chitosan derivatives interact electrostatically. Thus, many chitosan conjugates have cationic components such as ammonium, pyridinium or piperazinium substituents introduced into their molecules to increase their positive charge. Gram-positive bacteria like Staphylococcus aureus are inhibited by the binding of lower molecular weight chitosan derivatives to DNA or RNA. Chitosan nanoparticles exhibit an increase in loading capacity and efficacy. Antitumour active compounds such as doxorubicin, paclitaxel, docetaxel and norcantharidin are used as drug carriers. It is evident that chitosan, with its low molecular weight, is a useful carrier for molecular drugs requiring targeted delivery. The antioxidant scavenging activity of chitosan has been established by the strong hydrogen-donating ability of chitosan. The low molecular weight and greater degree of quarternization have a positive influence on the antioxidant activity of chitosan. Phenolic and polyphenolic compounds with antioxidant effects are condensed with chitosan to form mutual prodrugs.
650    _2
$a zvířata $7 D000818
650    _2
$a antiinfekční látky $x chemie $x farmakologie $x terapeutické užití $7 D000890
650    _2
$a antitumorózní látky $x chemie $x farmakologie $x terapeutické užití $7 D000970
650    _2
$a antioxidancia $x chemie $x farmakologie $x terapeutické užití $7 D000975
650    _2
$a chitosan $x analogy a deriváty $x chemie $x farmakologie $x terapeutické užití $7 D048271
650    _2
$a racionální návrh léčiv $7 D015195
650    _2
$a lidé $7 D006801
650    _2
$a molekulární struktura $7 D015394
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Vavříková, Eva $u Charles University, Faculty of Pharmacy, Department of Inorganic and Organic Chemistry, Hradec Králové, Czech Republic $7 xx0126311
773    0_
$w MED00007893 $t Current pharmaceutical design $x 1873-4286 $g Roč. 17, č. 32 (2011), s. 3596-3607
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22074429 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120806 $b ABA008
991    __
$a 20160308083228 $b ABA008
999    __
$a ok $b bmc $g 944118 $s 779502
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 17 $c 32 $d 3596-3607 $i 1873-4286 $m Current pharmaceutical design $n Curr Pharm Des $x MED00007893
GRA    __
$a NS10367 $p MZ0
LZP    __
$b NLK111 $a Pubmed-20120806/12/01

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...